Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Major Depressive Disorder
Interventions
DRUG

CX157

CX157 Modified Release Tablet 125 mg administered twice per day on study days 4-11 and in the morning of study day 12.

OTHER

Placebo

Placebo administered twice per day on study days 4-11 and in the morning of day 12.

Trial Locations (1)

33025

Comprehensive Phase One, Miramar

Sponsors
All Listed Sponsors
lead

CeNeRx BioPharma Inc.

INDUSTRY

NCT01633437 - Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter